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e investigated the relationship between PS1 and
 
 
 
-secretase processing of amyloid precursor
protein (APP) in primary cultures of neurons. In-
creasing the amount of APP at the cell surface or towards
 
endosomes did not signiﬁcantly affect PS1-dependent
 
 
 
-secretase cleavage, although little PS1 is present in those
subcellular compartments. In contrast, almost no 
 
 
 
-secre-
tase processing was observed when holo-APP or APP-C99,
a direct substrate for 
 
 
 
-secretase, were speciﬁcally retained
in the endoplasmic reticulum (ER) by a double lysine reten-
 
tion motif. Nevertheless, APP-C99-dilysine (KK) colocalized
with PS1 in the ER. In contrast, APP-C99 did not colocalize
with PS1, but was efﬁciently processed by PS1-dependent
W
 
 
 
-secretase. APP-C99 resides in a compartment that is neg-
ative for ER, intermediate compartment, and Golgi marker
proteins. We conclude that 
 
 
 
-secretase cleavage of APP-
C99 occurs in a specialized subcellular compartment
where little or no PS1 is detected. This suggests that at least
one other factor than PS1, located downstream of the ER, is
required for the 
 
 
 
-cleavage of APP-C99. In agreement, we
found that intracellular 
 
 
 
-secretase processing of APP-C99-
KK both at the 
 
 
 
40 and the 
 
 
 
42 site could be restored par-
tially after brefeldin A treatment. Our data conﬁrm the
“spatial paradox” and raise several questions regarding the
PS1 is 
 
 
 
-secretase hypothesis.
 
Introduction
 
Amyloid precursor protein (APP)* and presenilins (PSs) are
key proteins in the pathogenesis of Alzheimer’s disease
(Selkoe, 1999). PSs are multimembrane-spanning domain
proteins, essentially located in the ER, the intermediate
compartment, and the cis-Golgi region (Walter et al., 1996;
Culvenor et al., 1997; Annaert et al., 1999; Kim et al.,
2000). Some evidence for the presence of minute amounts
of PS at the cell surface has been provided (Ray et al., 1999).
APP is a type I transmembrane protein processed by secre-
tases, resulting in the generation of various fragments, most
notoriously the amyloid peptide (A
 
 
 
). Aggregation of this
peptide is considered to be a central event in the process
leading to Alzheimer’s disease (Selkoe, 1999). The 
 
 
 
-secre-
 
tase BACE (
 
 
 
-site amyloid cleaving enzyme) has been iden-
tified recently. It is an aspartyl protease cleaving APP at the
NH
 
2
 
 terminus of the amyloid peptide sequence (Vassar et
al., 1999). The 
 
 
 
-secretase cleaves in the A
 
 
 
 sequence itself,
precluding further A
 
 
 
 production. Several members of the
ADAM family (a disintegrin and metalloprotease), i.e., TACE,
MDC9, and ADAM10, have been implied in 
 
 
 
-secretase
processing of APP (Buxbaum et al., 1998; Koike et al., 1999;
Lammich et al., 1999). Finally, presenilin 1 (PS1)-depen-
dent 
 
 
 
-secretase cleavage of APP releases the COOH termi-
nus of the amyloid peptide (De Strooper et al., 1998).
PS-dependent 
 
 
 
-secretase activities are also involved in the
processing of other integral membrane proteins like Notch
and APLP-1 (De Strooper et al., 1999; Naruse et al., 1998;
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Song et al., 1999; Struhl and Greenwald, 1999). This
 
 
 
-secretase cleavage is a novel type of proteolytic processing,
occurring in the hydrophobic environment of the cell mem-
brane. In the case of Notch, the cleavage results in the
release of its intracellular domain that regulates gene tran-
scription in a process that has been called “regulated in-
tramembrane proteolysis” (Annaert and De Strooper, 1999;
Brown et al., 2000).
Several lines of evidence have led to the hypothesis that PS
is the 
 
 
 
-secretase. First, 
 
 
 
-secretase cleavage of APP and
Notch is inactivated partially in PS1-deficient cells and com-
pletely in PS1/PS2 double–deficient cells (De Strooper et
al., 1998, 1999; Song et al., 1999; Struhl and Greenwald,
1999; Herreman et al., 2000; Zhang et al., 2000). More-
over, mutagenesis of one or two aspartyl residues located in
transmembrane domain 6 or 7 results in dominant nega-
tive–like effects on 
 
 
 
-secretase cleavage, suggesting that these
aspartates contribute to the active site of PS (Wolfe et al.,
1999). Some similarities with the prepilin peptidases has
been taken as further evidence that the PS are proteases
(Steiner et al., 2000). However, the strongest argument in
favor for this idea comes from the observation that several
compounds that inhibit 
 
 
 
-secretase bind specifically to PS
(Esler et al., 2000; Li et al., 2000; Seiffert et al., 2000). Nev-
ertheless, direct proof that the PS can hydrolyze peptide
bounds is still lacking.
Remarkably, both Notch and APP apparently first need
proteolytical trimming of their extracellular domain by
TACE and 
 
 
 
-/
 
 
 
-secretase, respectively, to become a sub-
strate for PS/
 
 
 
-secretase (De Strooper et al., 1998; Brou et
al., 2000; Mumm et al., 2000; Struhl and Adachi, 2000).
These proteases are located downstream in the biosynthetic
pathway and therefore both Notch and APP first have to
leave the ER to become a substrate for PS/
 
 
 
-secretase. De-
spite significant advances in our understanding of 
 
 
 
-secre-
tase processing, it remains unclear how APP, after its cleav-
age by 
 
 
 
- or 
 
 
 
-secretase, becomes exposed to PS. Moreover,
A
 
 
 
 appears to be produced mainly in the endosomal com-
partment (Koo and Squazzo, 1994; Hartmann et al., 1997),
whereas PS is abundantly present in the ER and intermedi-
ate compartment (Walter et al., 1996; Culvenor et al., 1997;
Annaert et al., 1999; Kim et al., 2000). This problem can be
summarized as “the spatial paradox” (Annaert and De
Strooper, 1999) and we now tackle this problem further by
analyzing the processing of a series of APP-trafficking mu-
tants in primary cortical neurons derived from PS1
 
 
 
/
 
 
 
 or
PS1
 
 
 
/
 
 
 
 mice. We analyzed the consequences of restricting
APP trafficking to certain subcellular compartments for the
generation of total A
 
 
 
 and A
 
 
 
42. Constructs tested: (a) APP
with deleted cytosolic tail (APP-
 
 
 
ct); (b) APP with a double
lysine ER retention motif in its cytoplasmic tail (APP-KK);
(c) APP with a cytoplasmic tail from the LDL receptor
(APP-LDL); (d) APP truncated at the 
 
 
 
-secretase cleavage
site (APP-C99); and (e) APP-C99 with a double lysine (KK)
motif. The APP-
 
 
 
ct is poorly reinternalized and stays for
longer times at the cell surface (Tienari et al., 1996). The
KK motif acts an ER-retrieval signal (Jackson et al., 1993;
Gaynor et al., 1994) and therefore APP-KK colocalizes
abundantly with endogenous PS1 (Peraus et al., 1997; An-
naert et al., 1999). The APP-LDL recycles between the en-
 
dosomal system and the cell surface (Annaert et al., 1999).
APP-C99 is a direct substrate for 
 
 
 
-secretase and after addi-
tion of the KK ER retention motif (APP-C99-KK) we antic-
ipated creating an excellent substrate for PS1/
 
 
 
-secretase.
Overall, our data confirm the spatial paradox in the PS-is-
 
 
 
-secretase hypothesis and provide evidence that the transfer
of APP-C99 in a compartment downstream of the ER is
needed in addition to processed PS1 to obtain 
 
 
 
-secretase
activity in primary cultures of neurons.
 
Results
 
Different APP-trafficking mutants (Fig. 1) were expressed in
primary cortical neurons derived from PS1
 
 
 
/
 
 
 
 and PS1
 
 
 
/
 
 
 
littermate embryos. Metabolically labeled full-length APP
and secretase-cleaved APP fragments were immunoprecipi-
tated and analyzed by phosphorimaging as described in Ma-
terials and methods. For all constructs, protein expression
levels are very similar in PS1
 
 
 
/
 
 
 
 and in PS1
 
 
 
/
 
 
 
 cells (Fig.
2 A). Both full-length wild-type and APP-LDL chimera run
as a doublet (Fig. 2 A) of 
 
 
 
120 kD, corresponding to
mature- and immature-glycosylated APP. The majority for
both the APP-KK and APP-
 
 
 
ct recombinant proteins is,
however, the immature protein. This is expected for APP-
KK, as the dilysine motif actively retains the protein in pre-
Golgi compartments. The stronger immature APP-
 
 
 
ct band
could reflect the rapid processing of the mature form by
 
 
 
-secretase at the cell surface (Tienari et al., 1997). Next, we
analyzed proteolytic fragments derived from the different
APP mutants. Secretion of the soluble ectodomain after 
 
 
 
-
Figure 1. APP-trafficking mutants. APP is schematically repre-
sented (APP-WT). The different relevant proteolytic fragments are 
indicated at the top. The ectodomain is detected by pAb207, the 
amyloid peptide region 1–16 is detected by pAb B7, region 1–5 by 
mAb 3D6, region 17–24 is detected by mAb4G8, and the last 20 
amino acids of the COOH-terminal cytoplasmic tail are detected by 
pAb B11/4 and pAb 6687.  -,  -, and  -secretase cleavage sites are 
indicated. In the APP-C99 construct, a supplementary Asp and Ala 
residue (DA) has been added to obtain cleavage by the signal pepti-
dase at the  -secretase site (see Lichtenthaler et al., 1999). For 
further details see Materials and methods. 
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or 
 
 
 
-secretase cleavage generated from the different traffick-
ing mutants was not significantly altered by PS1 deficiency,
although the APP-
 
 
 
ct, for instance, produced roughly twice
as many APPs (Fig. 2). 
 
 
 
-Cleaved COOH-terminal stubs
(APP-CTF) derived from APP-WT accumulated strongly in
PS1
 
 
 
/
 
 
 
 neurons (Fig. 2 B), confirming previous data (De
Strooper et al., 1998). Interestingly, the same relative accu-
mulation was observed for APP-CTF derived from the APP-
LDL chimera. Also, total A
 
 
 
 secretion was severely de-
creased in PS1
 
 
 
/
 
 
 
 neurons transduced for APP-WT and
Figure 2. Processing of APP trafficking mutants in PS1 /  
and PS1 /  neurons. (A) PS1 /  or PS1 /  primary neu-
ronal cultures were transduced with pSFV bearing APP-WT, 
APP- ct, APP-KK, or APP-LDL as described, and metabolically 
labeled with [
35S]methionine for 4 h at 37 C. Cell extracts (two 
top panels) and culture media (two bottom panels) were immu-
noprecipitated using the appropriate antibodies and analyzed 
on 10% or 4–12% NuPage gels. The position of the various 
APP fragments is indicated. Note that the APP- ct holo-forms 
and COOH-terminal  -fragments migrate faster because the 
cytoplasmic domain is deleted, whereas the APP-LDL frag-
ments migrates slower due to the large LDL receptor cytoplas-
mic domain. The COOH-terminal  -stub is not detected here 
because antibody B7 does not react with that fragment. (B) APP 
fragments from three independent experiments were quantified 
using PhosphorImaging and normalized to the level of expres-
sion of the APP holo-forms (De Strooper et al., 1995, 1998; 
Annaert et al., 1999). Data obtained in the PS1 /  neurons are 
compared with the data obtained in the PS1 /  neurons. This 
shows the relative effect of the absence of PS1 on each APP 
fragment separately. Since APP- ct is processed by  -secretase 
to a limited extent only, the results displayed in Fig. 3 are more 
significant for conclusions regarding the level of  -secretase 
processing of this construct. (C) The secretion of A 42 was 
analyzed by ELISA. All results are normalized to the level se-
creted by PS1 /  neurons transfected with APP-WT. Dark bars 
and light bars represent data obtained in PS1 /  and PS1 /  
neurons, respectively.734 The Journal of Cell Biology | Volume 154, 2001
APP-LDL (Fig. 2 B). Although the secretion of A 42 de-
rived from APP-LDL is reduced by 80% in PS1 /  neu-
rons, in line with previous observations (Koo and Squazzo,
1994; Perez et al., 1999), the additional relative decrease
caused by PS1 /  deficiency remained unaltered when
compared with APP-WT (Fig. 2, B and C). Together, these
data suggest that in the case of the APP-LDL chimera, the
enhanced recycling in the endosomal limb does not directly
influence PS1-dependent  -secretase processing.
The reduction of  -cleaved APP-CTF in the APP- ct–
transduced wild-type neurons is accompanied by an 80%
decrease in secretion of total A  and A 42 (Fig. 2, A and
C). Moreover, no relative accumulation of  -cleaved APP-
CTF in PS1 /  neurons was observed. All this can be ex-
plained by a predominant  -secretase cleavage of APP- ct at
or near the plasma membrane, as reflected by the increased
secretion of APPs cleaved at the  -secretase site and the con-
comitant fivefold increase in p3 secretion (Fig. 3). Interest-
ingly, secretion of p3 is dramatically inhibited in the absence
of PS1 (Fig. 3, bottom), indicating that  -stubs generated
near or at the cell surface are still substrates for PS1-depen-
dent  -secretase processing. Therefore, the data on APP- ct
and APP-LDL clearly demonstrate that PS1 is needed for
normal  -secretase processing in the late Golgi region, at the
cell surface, and in the endosomal compartments.
In contrast to the other mutants, the levels of APPs and of
the COOH-terminal  -stubs generated from APP-KK are
very low, confirming the low  - and  -secretase activity in
the ER (Fig. 2, A and B). Accordingly, the total A  (Fig. 2
B) and A 42 (Fig. 2 C) secretion was also strongly reduced
by 90%. However, when overexpressed in PS1 /  neu-
Figure 3. Secretion of p3 in PS1 /  and  /  neurons express-
ing APP- ct. Neurons were transduced and metabolically labeled 
as above. Cell extracts (top) and culture media (bottom) were 
immunoprecipitated using pAb207 (holo-APP) or mAb4G8 ( APPs 
and A /p3). The intermediate band running between A  and p3 in 
cells transduced with APP-WT corresponds to the truncated A  
generated by  -secretase cleavage at the Glu11 position (Creemers 
et al., 2000).
rons, secretion of A  peptides was inhibited to the same ex-
tent as observed for peptides derived from APP-WT (Fig. 2,
B and C).
To circumvent the need for “preactivation” of APP-KK by
 - or  -secretase, we generated APP-C99-KK, corresponding
to APP truncated at the  -secretase site (Lichtenthaler et al.,
1999) and containing the KK-ER retention motif. When ex-
pressed in neurons, APP-C99-KK migrated with the same
apparent molecular weight (10 kD) as the  -stub coming
from APP-WT or the APP-C99 without KK motif (Fig. 4 A;
Lichtenthaler et al., 1999). APP-C99, like APP-WT, can be
processed by  -secretase as reflected by the generation of
 -APPCTF (Fig. 4 A). APP-C99-KK, in contrast, is either
not processed or processed very little by  - or  -secretase,
confirming the specific retention of APP-C99-KK in the ER
and cis-Golgi region. In line with the prediction that APP-
C99 does not require  - or  -secretase cleavage to become a
substrate for  -secretase, an estimated sevenfold increase in
total A  secretion (Fig. 4 A) is observed. This effect is also
observed with A 42, as detected by ELISA (Fig. 4 B). The
 -secretase cleavage of APP-C99 is strongly inhibited in the
absence of PS1 (Fig. 4 C). Most surprisingly, however, was
the observation that APP-C99-KK, which was also expected
to be a substrate for PS1- -secretase because it is retained in
the ER, turned out to yield little if any A  peptides (Fig. 4, A
and B). It is unlikely that the KK motif directly interfered
with the recognition of C99 by the  -secretase complex, since
the cytoplasmic tail of APP can be removed without affecting
 -secretase cleavage (Fig. 3). Moreover, C99KK becomes a
substrate for  -secretase under conditions specified below.
Alternatively, the low A  secretion from neurons expressing
APP-C99-KK might be explained by intracellular retention
of newly formed A  peptides. Again, this could be ruled out,
as no increased amounts of A  could be immunoprecipitated
from cell extracts (result not shown, but see Fig. 7 below).
Using confocal scanning microscopy, we confirmed that
APP-C99-KK was effectively retained in the ER, as demon-
strated by its colocalization with the ER marker protein BIP
(Fig. 5, A–C), and to a more limited extent with the interme-
diate compartment marker ERGIC-53 (Fig. 5, G–I). Impor-
tantly, APP-C99-KK colocalized abundantly with PS1 (Fig. 5,
D–F), indicating that the simple presence of PS1 is not suffi-
cient for  -secretase processing to occur. In this respect, it is
important to note that we have demonstrated previously that
PS1 in the ER is already processed towards NH2- and COOH-
terminal fragments (Annaert et al., 1999). We next investi-
gated the subcellular localization of APP-C99 in primary corti-
cal neurons. APP-C99 is clearly not distributed in the ER (Fig.
6, A–C), as deduced from the complete lack of colocalization
with BIP. Similarly, little if any colocalization was observed
with ERGIC-53 marking the intermediate compartment (ar-
rowheads in Fig. 6, D–F, including horizontal section [ar-
row]). Most surprisingly, however, was the observation that
APP-C99 immunoreactivity also essentially did not distribute
into the Golgi apparatus as demonstrated by GM130 staining
(Fig. 6, G–I). Finally, and despite APP-C99 being a good
 -secretase substrate (Fig. 4), this fragment does not colocalize
with PS1 (arrowheads and vertical section in Fig. 6, J–L). This
is in clear contrast to the colocalization of PS1 with the inactive
 -secretase substrate APP-C99-KK (see also Fig. 5).The spatial paradox in APP processing | Cupers et al. 735
To test the hypothesis that a component of a more down-
stream subcellular compartment is needed to process APP-
C99-KK in the ER, we treated neurons expressing APP-C99
or APP-C99-KK with brefeldin A (BFA), a drug that causes
a rapid redistribution of the Golgi apparatus into the ER
(Lippincott-Schwartz et al., 1989). This treatment resulted
in a drastic reduction in APP-C99–derived A  secretion,
whereas no difference was observed in the case of APP-C99-
KK (Fig. 7 A). However, addition of BFA resulted in a strong
increase in intracellular A  generated from APP-C99-KK,
towards levels indistinguishable from those obtained in
BFA-treated APP-C99–transduced cells. This suggests that
some unknown factors required for  -secretase activity are
redistributed from the Golgi region to the ER, which ap-
pears to be sufficient to partially restore A  production from
APP-C99-KK. It has been suggested that A  generated in
the endoplasmic reticulum consists mainly of A  ending at
residue 42 (Chyung et al., 1997; Cook et al., 1997; Hart-
mann et al., 1997; Wild-Bode et al., 1997). Remarkably, al-
though we detect little intracellular A  under our experi-
mental conditions (Fig. 7, A and B), treatment with BFA
induces the generation of A  peptides, ending at residue 40
as well as at residue 42 (Fig. 7 B).
Discussion
Previous studies (Koo and Squazzo, 1994; Hartmann et al.,
1997; Tienari et al., 1997) have shown that A  can be gen-
erated at the cell surface and in the endosomes of neurons,
where little, if any, PS1 is present (Annaert et al., 1999).
The first aim of the current study was to investigate to what
extent  -secretase activity in these subcellular compartments
depends indeed on PS1. To this end we expressed APP- ct
and APP-LDL, two previously characterized trafficking mu-
tants of APP (Peraus et al., 1997; Tienari et al., 1997; An-
naert et al., 1999), in neurons. APP- ct lacks the endocyto-
sis signals in the cytoplasmic domain of APP and is therefore
only slowly internalized. Compared with APP-WT, APP-
 ct is processed mainly by an  -secretase activity at the cell
surface (Sisodia, 1992; Tienari et al., 1997; Annaert et al.,
1999). This results in the replacement of A  production by
a roughly equal production of p3, the product of consecu-
tive  - and  -secretase activity (Figs. 2 and 3), confirming
that the APP- ct construct indeed behaves as predicted.
Therefore, p3 production from this substrate reflects mainly
 -secretase cleavage of the  -APPCTF at the cell surface.
Expression of this construct in PS1-deficient neurons re-
sulted in a strong decrease of p3, demonstrating that  -secre-
tase cleavage at the cell surface depends on PS1 (Fig. 3). Since
 APPs secretion is not affected in the absence of PS1 (Fig.
3), we rule out the possibility that the decreased p3 produc-
tion is caused by decreased  -secretase activity in these PS1-
deficient cells.
APP-LDL expression selectively increased A 40 secretion,
as predicted from its preferential localization in the endo-
the absence of PS1 on A  production from APP-WT and from 
APP-C99. The A  signals obtained with APP-C99-KK are below 
detection limit.
Figure 4.  -secretase processing of APP-C99 trafficking mutants 
in PS1 /  and PS1 /  neurons. (A) Cells extracts (top) and 
culture media (bottom) of neurons expressing APP-WT, APP-C99, 
or APP-C99-KK were immunoprecipitated using antibodies B11/4 
against the APP COOH-terminal domain (top), or B7 against the 
amyloid region. Arrows on the gels indicate the position of the 
various APP fragments. Notice the striking absence of A  genera-
tion with APP-C99-KK. The 6.5-kD stub seen with APP-C99 and 
APP-C99-KK is PS1-independent and probably not physiologically 
relevant, since it is never observed with APP-WT. (B) A 42 levels 
were measured by ELISA as in Fig. 2 B. Results are expressed rela-
tively to those obtained for PS1 /  neurons transfected with APP-
WT. NS, nonsignificant (values below detection limit). (C) A -frag-
ments were quantified using PhosphorImaging and normalized to 
the level of expression of the APP holo-forms (n   3; mean   SEM). 
Data obtained in the PS1 /  neurons are compared with the data 
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somes (Koo and Squazzo, 1994; Peraus et al., 1997; Perez et
al., 1999). Again, in the absence of PS1, A  generation from
APP-LDL strongly decreased, demonstrating that  -secre-
tase processing of APP in the endosomes depends on PS1. It
should be noted that we have not been able to detect any en-
dogenous PS1 immunoreactivity at the cell surface or in the
endosomes of the neuronal cells used in the current study
(Annaert et al., 1999).
We next investigated whether we could increase  -secre-
tase processing of APP in the ER and the intermediate com-
partment, which contain the bulk of PS1 immunoreactivity
in these neurons. Although several authors have provided
evidence that the ER is a production site of this peptide, in
particular A 42 (Chyung et al., 1997; Cook et al., 1997;
Hartmann et al., 1997; Wild-Bode et al., 1997), we and
others have not been able to confirm these observations
(Annaert et al., 1999; Iwata et al., 2001; Maltese et al.,
2001). As shown in Fig. 2, a severe decrease in both A 40
and A 42 secretion is observed when APP is retained in the
ER by means of the double lysine retention motif (APP-
KK). Since the retention of APP in the ER implies that
cleavage by  - and  -secretase (residing in the TGN, cell
surface, and endosomes) becomes strongly compromised,
and since proteolytic trimming of the APP ectodomain is a
prerequisite for further  -secretase processing (Struhl and
Adachi, 2000), it seems logical that the APP-KK mutation
results in a strongly decreased  -secretase cleavage and inhi-
bition of A  generation. It is by consequence difficult to in-
terpret the data obtained with APP-KK in regard to  -secre-
tase sensitivity. Therefore, we generated the APP-C99
construct, which is a direct substrate for  -secretase (Lichten-
thaler et al., 1999), and added to it the double lysine ER re-
tention motif. As shown in Fig. 5, this construct is indeed
retained in the ER, where it codistributes abundantly with
PS1. Although we expected increased A  production, no
significant amount of A  could be precipitated from the
wild-type neurons (Fig. 4; Iwata et al., 2001; Maltese et al.,
2001). This result was even more significant, as neurons ex-
pressing APP-C99 secreted about seven times more total
A , or specifically A 42, than those expressing APP-WT.
The possibility that the A  generated from APP-C99-KK is
retained in the cells was ruled out, since no significant accu-
mulation of cells associated A  could be demonstrated (Fig.
7 A, lane 9, and B, lanes 2 and 5)The possibility that the
KK motif directly interfered with  -secretase cleavage was
ruled out by two observations. First, it is clear from the re-
sults with APP- ct that the cytoplasmic domain of APP is
not involved in the processing of APP by  -secretase. Sec-
ond, treatment of the cell cultures with BFA could restore
the processing of C99-KK, clearly demonstrating that the
inhibitory effect of the KK mutations is a trans, and not a
cis phenomenon (Fig. 7). It should be pointed out here that
PS1 in the ER is already proteolytically processed by the
“presenilinase” and present as PS1-CTF and PS1-NTF (An-
naert et al., 1999), thus in the putative active conformation.
It follows from these data that the simple colocalization of a
substrate (APP-C99-KK) with its putative protease (PS1) is
not sufficient for proteolytic cleavage.
We conclude that A  production, including A 42, can
not occur directly in the ER and requires at least one factor
Figure 5. APP-C99-KK colocalizes with PS1 
in the endoplasmic reticulum. Hippocampal 
neurons transduced with SFV-APP-C99-KK 
were fixed 6 h postinfection and stained with 
an antibody against APP (A with pab 6687; 
D and G with mab 3D6) and BIP (B), PS1 (E), or 
ERGIC-53 (H). C, F, and I represent the merged 
pictures. APP-C99-KK abundantly colocalized 
with the ER-marker protein BIP and with PS1. 
Little if any colocalization was observed with 
ERGIC-53, a resident protein of the intermedi-
ate compartment. Detection of primary anti-
bodies was done with Alexa 488– and Alexa 
546–conjugated goat anti–mouse or goat anti–
rabbit secondary antibodies (1/1,000 diluted). 
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derived from a post-ER compartment. This conclusion is
corroborated by two important pieces of evidence from the
current work. First, APP-C99, which is a good substrate for
 -secretase, is mainly localized in a PS1-, BIP-, and
ERGIC53-negative subcellular compartment (Fig. 6). Al-
though the characterization of this compartment requires
further experimentation, this result suggests that at least the
proteolytic cleavage of the APP-C99 substrate occurs in a
non-ER compartment. The second, more important argu-
ment comes from the experiments using BFA. BFA is a drug
that causes the redistribution of post-ER compartments into
the ER (Lippincott-Schwartz et al., 1989). Treatment with
this drug was sufficient to restore partially  -secretase pro-
cessing of APP-C99-KK proving that at least one non-ER
component is needed to activate  -secretase in the ER (Fig.
7). BFA treatment results in  -secretase processing of APP at
position A 42, something which could possibly be antici-
pated based on current knowledge (Chyung et al., 1997;
Cook et al., 1997; Hartmann et al., 1997; Wild-Bode et al.,
1997). Surprisingly, however, cleavage at position A 40 is
also observed (Fig. 7 B), which is believed to occur mainly in
the late compartments of the secretory and in the endosomal
limbs of the subcellular trafficking pathways (Koo and
Squazzo, 1994; Hartmann et al., 1997; Tienari et al., 1997).
Summarizing, our data indicate that efficient  -secretase
cleavage of APP can occur in compartments that contain lit-
tle, if any, PS1, and that no or little  -secretase activity is ob-
served in compartments where abundant (maturated) PS1 is
residing. This is a surprising result since most of the data
currently available imply that PS1 is closely involved in
 -secretase type enzymatic activity (De Strooper et al., 1998,
1999; Steiner et al., 1999, 2000; Struhl and Greenwald,
1999; Wolfe et al., 1999; Esler et al., 2000; Herreman et al.,
2000; Li et al., 2000; Zhang et al., 2000). The spatial para-
dox between PS1 localization and  -secretase activity can be
explained by two hypotheses: (a) the minute amounts of PS1
in post–cis-Golgi compartments are the active enzymes.
This implies that in addition to activation by presenilinase,
additional proteins from these compartments are needed to
make PS1 enzymatically active; and (b) PS1 is actually not
the  -secretase but acts, probably in concert with other pro-
teins in the ER and intermediate compartment, to dispatch
APP or  -secretase to the subcellular compartment where
cleavage will occur. In this hypothesis, BFA treatment results
in the relocalization of the catalytic subunit(s) of  -secretase
to the ER.
In support for the first hypothesis, evidence for the pres-
ence of minute amounts of PS1 in other compartments than
Figure 6. APP-C99 does not colocalize with PS1 
and is essentially present in a BIP, ERGIC-53, and 
GM130 negative compartment. SFV-APP-C99 
transduced hippocampal neurons were fixed and 
the subcellular localization of APP-C99 (A and G 
with pAb 6687; D and J with mAb 3D6) was 
compared with established marker proteins of 
the ER (BIP in B), the intermediate compartment 
(ERGIC-53 in E), the Golgi apparatus (GM130 in 
H), and finally with PS1 (K). C, F, I, and L show 
merged pictures. For D–F and J–L, the arrows 
point to the position of the corresponding vertical 
sections. Immunodetection was done as in Fig. 6. 
APP-C99 immunoreactivity was mainly concen-
trated in discrete spots that did not colocalize 
with the ER (C for BIP and arrowheads in L for 
PS1), and the Golgi region (merged panel I). 
Occasionally minor colocalization with ERGIC-
53 could be observed (arrowheads in D–F). Bar, 
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the ER has been provided. In some studies, the specificity of
the antibodies used can be questioned (Dewji and Singer,
1997), but in polarized cell types like MDCK cells (Georga-
kopoulos et al., 1999) or in specialized cell membranes like
growth cones or lamellipodia (Schwarzman et al., 1999),
some PS1 seems to be located near or at the cell surface. Ray
et al. (1999) provided evidence that PS1 can travel in com-
plex with Notch to the cell surface, albeit that this conclusion
was based on a single type of experimental approach, i.e., cell
surface biotinylation. Furthermore, the hypothesis that PS
travels together with its substrates from the ER to the cell sur-
face and becomes activated there is probably not tenable if
one takes into account that the relative amount of PS1 to its
substrates is extremely low (Thinakaran et al., 1998). If PS1
needs to accompany every substrate that it will cleave from
the ER to the cell surface, it becomes, given the limited
amounts of PS available in any cell type, difficult to under-
stand why strong overexpression of APP does not saturate the
system and does not lead to inefficient  -secretase processing.
Although it remains impossible to exclude that minute
amounts of PS1 in the endosomes or at the cell surface are
the active enzymes, it is clear that this hypothesis raises sev-
eral new questions that need to be addressed. In addition,
the function of the “inactive” pool of PS1 in the ER also re-
mains to be explained. From the BFA experiments it follows
that at least one other component of a non-ER compart-
ment is needed to obtain activated PS1. This component is
not the elusive protease called “presenilinase” responsible for
PS maturation, and most probably not nicastrin, since this
protein is present in the ER (Yu et al., 2000).
The second hypothesis, that PS1 is needed for the correct
trafficking of  -secretase and its substrates, finds some theo-
retical support in the analogy with the sterol regulatory ele-
ment–binding protein (SREBP)–SCREB cleavage–activat-
ing protein (SCAP) complex and the regulation of the
proteolytical cleavage of SREBP (Brown et al., 2000). SCAP
is, like PS1, an ER resident, multitransmembrane domain–
containing protein and regulates the trafficking of the mem-
brane-bound transcription factor SREBP to post-ER com-
partments. Upon cholesterol depletion, SREBP travels to
the cis-Golgi, where a site 1 protease cleaves SREBP in its
luminal domain. The remaining NH2-terminal, membrane-
bound fragment then becomes a substrate for a site 2 pro-
tease that cleaves in the transmembrane domain of SREBP
(Rawson et al., 1997; Nohturfft et al., 1999). The coupling
of vesicular protein transport and proteolysis provides a
stringent control on the activation of the system and it could
be envisaged that PS1, like SCAP, provides a similar control
on APP (and Notch) processing. However, it should be
pointed out that in case of SREBP processing, SCAP regu-
lates its luminal cleavage and that the site 2 intramembrane-
ous cleavage occurs by default. In case of PS1, its role is lim-
ited to the regulation of the intramembraneous  -secretase
cleavage (De Strooper et al., 1998).
In conclusion, our data indicate a complex relationship
between APP trafficking and its processing by  -secretase.
Moreover, they directly question the exact role of PS1 in
 -secretase processing and demonstrate that at least one co-
factor (in the first hypothesis) or the protease (in the second
hypothesis) is located in a compartment downstream of the
ER. In the future, reconstitution of  -secretase processing of
APP, by mixing extracts of purified ER fractions and post-
ER compartments, should allow us to further define at a
molecular level this highly intriguing proteolytic system.
Materials and methods
Neuronal cell culture
Primary cultures of mixed cortical neurons derived from wild-type and PS1
knock-out littermates were generated as described previously (De Strooper
et al., 1998). In brief, total brain of 14-d-old embryos was dissected in
HBSS medium (GIBCO BRL), trypsinized, and plated on dishes (Nunc) pre-
coated with poly-L-lysine (Sigma-Aldrich). Cultures were maintained in
neurobasal medium (GIBCO BRL) with B27 supplement (GIBCO BRL) and
5  M cytosine arabinoside to prevent glial cell proliferation.
Semliki forest virus (SFV) constructs
The following modifications were made to the cDNA coding for human
APP695 (Fig. 1): (a) deletion of the last 43 amino acids of the cytoplasmic
tail (APP- ct) as described in Tienari et al. (1996); (b) addition of a di-lysine
motif (QM mutated to KK, APP-KK) by site-directed mutagenesis (Strat-
agene); (c) exchange of its cytoplasmic domain with that of the LDL receptor
(APP-LDL); (d) full deletion of the APP ectodomain until the Asp1 amino
acid of the amyloid peptide region ( -secretase site). An additional AspAla
(DA) was cloned by site-directed mutagenesis (Stratagene) between the last
amino acid of the signal sequence (Ala) and the first of the A  region (Lichten-
thaler et al., 1999) (APP-C99). Site-directed mutagenesis was used to add the
di-lysine motif (APP-C99-KK). Recombinant SFV containing the APP mutants
were generated as described previously (De Strooper et al., 1995).
Figure 7. BFA treatment partially restores  -secretase processing 
of APP-C99-KK. Neurons were transduced with SFV-APP-C99 
or -APP-C99-KK and treated with or without 10  M BFA for 4 h. 
Culture media and cell extracts were immunoprecipitated using 
antibody B7 and separated on 10% NuPage gels. Detection of 
secreted and intracellular A  was done by Western blotting using 
the W0-2 mAb raised against the NH2 terminus of the A  sequence 
(Ida et al., 1996). Neurons transduced with SFV-APP-C99-KK were 
treated with BFA as above. Cell extracts were sequentially immuno-
precipitated using antibody FCA42, specific for A  peptides ending 
at residue 42 and FCA40, specific for A  peptides ending at residue 
42 (Barelli et al., 1997), and separated on 10% NuPage gels. After 
blotting, A  peptides were revealed using the WO-2 mAb as above.The spatial paradox in APP processing | Cupers et al. 739
Transduction and metabolic labeling of neuronal cell cultures
Recombinant SFV was diluted 10-fold in neurobasal medium and added
to the culture dishes. After a 1-h incubation at 37 C, fresh neurobasal
medium was added. After 2 h, cells were metabolically labeled in me-
thionine-free MEM (GIBCO BRL) supplemented with B27 and 100  Ci/
ml [
35S]methionine (ICN Biomedicals). 10  M BFA (Epicentre) was added
when indicated. After 4 h, conditioned medium and cells were recov-
ered. Cells were lysed in IP buffer (20 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 1% Triton X-100, 1% sodium deoxycholate and 0.1% SDS) and
cleared by centrifugation. Labeled protein was immunoprecipitated us-
ing 25  l protein G Sepharose and specific antibodies as indicated below
and in Fig. 1. Immunoprecipitates were finally solubilized in 25  l Nu-
Page sample buffer (Invitrogen) and electrophoresed on 4–12% or 10%
acrylamide NuPage Bis-Tris gels under reducing conditions and MES in
the running buffer (Invitrogen). Results were analyzed using a Phosphor-
Imager (Molecular Dynamics) and ImagQuaNT4.1. All data were nor-
malized to the value obtained for the corresponding APP holoform to
normalize for variations between culture dishes. The following antibod-
ies were used (Fig. 1). Rabbit pAb B7 recognizes the first 17 amino acids
of A , B11 the last 20 amino acids of the APP COOH-terminal domain
(De Strooper et al., 1995), goat pAb 207 the APP ectodomain (provided
by Dr. M. Savage, Cephalon, Inc., West Chester, PA), mAb 4G8 (Senetek)
amino acids 17 to 24 of A , and mab W0-2 the NH2-terminal region of
A  (provided by Dr. Tobias Hartmann and Konrad Beyreuther, University
of Heidelberg, Heidelberg, Germany) (Ida et al., 1996). Antibodies
FCA40 and FCA42 specifically precipitate A  peptides ending at residue
40 ( 40) or at 42 ( 42) and were provided by Dr. F. Checler (Institut de
Pharmacologie Moléculaire et Cellulaire, Valbonne, France) (Barelli et
al., 1997).
Quantification of the A 42 peptide by ELISA
Levels of A 42 in conditioned media and cell lysates were quantified by a
sandwich ELISA test (De Strooper et al., 1998), according to published pro-
tocols (Vanderstichele et al., 2000). In brief, samples were dried by speed
vacuum (Savant), resuspended in 300  l of sample diluent, and incubated
on 96-well ELISA plates precoated with mAb 3D6 against A . After wash-
ing, samples were incubated with a biotin-labeled anti-A 42 antibody
mAb 21F12 that only recognizes the final two amino acids of the A 42 se-
quence, followed by streptavidine-HRP. After adding the HRP substrate,
samples were measured spectrophotometrically using a Victor2 (Wallac)
with a 450-nm filter. The A 42 concentration in the samples was calcu-
lated based on the A 42 standards sigmoid curve equation, and using
Prism 3.0 (GraphPad Software).
Confocal microscopy
Hippocampal neurons grown on poly-L-lysine–coated glass coverslips in
the presence of a glial feeder layer (Goslin and Banker, 1991; De Strooper
et al., 1995) were transduced with SFV-APP-C99 or -C99KK. 4 h after
transduction, cycloheximide (100  g/ml) was added to block further pro-
tein synthesis. After 6 h, neurons were fixed in 120 mM phosphate buffer
containing 4% paraformaldehyde (pH 7.3) and 4% sucrose, permeabilized
in ice-cold methanol and acetone, and immunostained (Annaert et al.,
1999). Recombinant APP-C99 was detected with pAb 6687 (gift of Dr. C.
Haass, University of München, Germany) or mAb 3D6 (gift of Dr. Seubert,
Elan Pharmaceuticals, San Francisco, CA). mAbs to BIP were purchased
from Sigma. PAb B17.2 was used to detect endogenous PS1 (Annaert et al.,
1999). The intermediate compartment and Golgi region were identified us-
ing anti-ERGIC-53, provided by Dr. J. Saraste (University of Bergen, Nor-
way), and anti-GM130 (Transduction Laboratories), respectively. Alexa
488– and Alexa 546–conjugated secondary antibodies were from Molecu-
lar Probes. BioRad MRC1024 confocal microscope and Adobe Photoshop
®
5.2 were used for final processing (Annaert et al., 1999).
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